Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 Jul;41(7):1575–1578. doi: 10.1128/aac.41.7.1575

Effect of granulocyte colony-stimulating factor on the candidacidal activity of polymorphonuclear neutrophils and their collaboration with fluconazole.

U Natarajan 1, E Brummer 1, D A Stevens 1
PMCID: PMC163962  PMID: 9210688

Abstract

The effect of granulocyte colony-stimulating factor (GCSF) treatment of polymorphonuclear neutrophils (PMN) in vitro was studied with respect to their candidacidal activity. The candidacidal activity of PMN was found to be significantly increased when they were pretreated with GCSF. Fluconazole (1 microg/ml) was found to be highly fungistatic (90%) for Candida albicans Sh27 and collaborated with PMN for significantly increased killing. Collaborative killing by PMN significantly increased when they were treated with GCSF before and after fungal exposure. The enhancing activities of GCSF required optimization of the GCSF dose and were thus inoculum and strain dependent.

Full Text

The Full Text of this article is available as a PDF (132.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bermudez L. E., Inderlied C., Young L. S. Stimulation with cytokines enhances penetration of azithromycin into human macrophages. Antimicrob Agents Chemother. 1991 Dec;35(12):2625–2629. doi: 10.1128/aac.35.12.2625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bronchud M. H., Scarffe J. H., Thatcher N., Crowther D., Souza L. M., Alton N. K., Testa N. G., Dexter T. M. Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer. 1987 Dec;56(6):809–813. doi: 10.1038/bjc.1987.295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brummer E., Stevens D. A. Synergy of human neutrophils with fluconazole in killing Candida species. Mycopathologia. 1996;134(3):115–120. doi: 10.1007/BF00436717. [DOI] [PubMed] [Google Scholar]
  4. Dale D. C., Bonilla M. A., Davis M. W., Nakanishi A. M., Hammond W. P., Kurtzberg J., Wang W., Jakubowski A., Winton E., Lalezari P. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood. 1993 May 15;81(10):2496–2502. [PMC free article] [PubMed] [Google Scholar]
  5. Fromtling R. A., Galgiani J. N., Pfaller M. A., Espinel-Ingroff A., Bartizal K. F., Bartlett M. S., Body B. A., Frey C., Hall G., Roberts G. D. Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts. Antimicrob Agents Chemother. 1993 Jan;37(1):39–45. doi: 10.1128/aac.37.1.39. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Garcha U. K., Brummer E., Stevens D. A. Synergy of fluconazole with human monocytes or monocyte-derived macrophages for killing of Candida species. J Infect Dis. 1995 Dec;172(6):1620–1623. doi: 10.1093/infdis/172.6.1620. [DOI] [PubMed] [Google Scholar]
  7. Gujral S., Brummer E., Stevens D. A. Role of extended culture time on synergy of fluconazole and human monocyte-derived macrophages in clearing Candida albicans. J Infect Dis. 1996 Oct;174(4):888–890. doi: 10.1093/infdis/174.4.888. [DOI] [PubMed] [Google Scholar]
  8. Kimura S., Matsuda J., Ikematsu S., Miyazono K., Ito A., Nakahata T., Minamitani M., Shimada K., Shiokawa Y., Takaku F. Efficacy of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with AIDS. AIDS. 1990 Dec;4(12):1251–1255. doi: 10.1097/00002030-199012000-00011. [DOI] [PubMed] [Google Scholar]
  9. Morstyn G., Campbell L., Souza L. M., Alton N. K., Keech J., Green M., Sheridan W., Metcalf D., Fox R. Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet. 1988 Mar 26;1(8587):667–672. doi: 10.1016/s0140-6736(88)91475-4. [DOI] [PubMed] [Google Scholar]
  10. Peters W. P. The effect of recombinant human colony-stimulating factors on hematopoietic reconstitution following autologous bone marrow transplantation. Semin Hematol. 1989 Apr;26(2 Suppl 2):18–23. [PubMed] [Google Scholar]
  11. Roilides E., Uhlig K., Venzon D., Pizzo P. A., Walsh T. J. Neutrophil oxidative burst in response to blastoconidia and pseudohyphae of Candida albicans: augmentation by granulocyte colony-stimulating factor and interferon-gamma. J Infect Dis. 1992 Sep;166(3):668–673. doi: 10.1093/infdis/166.3.668. [DOI] [PubMed] [Google Scholar]
  12. Roilides E., Walsh T. J., Pizzo P. A., Rubin M. Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J Infect Dis. 1991 Mar;163(3):579–583. doi: 10.1093/infdis/163.3.579. [DOI] [PubMed] [Google Scholar]
  13. Shimokawa O., Nakayama H. Increased sensitivity of Candida albicans cells accumulating 14 alpha-methylated sterols to active oxygen: possible relevance to in vivo efficacies of azole antifungal agents. Antimicrob Agents Chemother. 1992 Aug;36(8):1626–1629. doi: 10.1128/aac.36.8.1626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Soll D. R., Langtimm C. J., McDowell J., Hicks J., Galask R. High-frequency switching in Candida strains isolated from vaginitis patients. J Clin Microbiol. 1987 Sep;25(9):1611–1622. doi: 10.1128/jcm.25.9.1611-1622.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Vecchiarelli A., Monari C., Baldelli F., Pietrella D., Retini C., Tascini C., Francisci D., Bistoni F. Beneficial effect of recombinant human granulocyte colony-stimulating factor on fungicidal activity of polymorphonuclear leukocytes from patients with AIDS. J Infect Dis. 1995 Jun;171(6):1448–1454. doi: 10.1093/infdis/171.6.1448. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES